A clinical overview of the fibromyalgia syndrome

Journal of Musculoskeletal Pain

Volumn 4, Issue 1-2, 1996, Pages 9-34

  McCain, Glenn A ^a,b  

^a CAROLINAS MEDICAL CENTER   (United States)

^b PRESBYTERIAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; CHLORPROMAZINE; CYCLOBENZAPRINE; DOXEPIN; FLUOXETINE; MAPROTILINE; PARACETAMOL; PAROXETINE; SERTRALINE; TRAZODONE; VENLAFAXINE;

BEHAVIOR THERAPY; CLINICAL FEATURE; DISEASE CLASSIFICATION; ELECTROACUPUNCTURE; EXERCISE; FIBROMYALGIA; HUMAN; HYPNOSIS; PAIN ASSESSMENT; REVIEW; TREATMENT PLANNING;

EID: 0029991041     PISSN: 10582452     EISSN: None     Source Type: Journal    
DOI: 10.1300/J094v04n01_04     Document Type: Review

References (79)

1. Merskey H: International Association for the Study of Pain Subcommittee on taxonomy, chronic pain syndromes and definition of pain terms. Pain Suppl 3: SI-S225, 1986.
2. The Subcommittee on Taxonomy International Association for the Study of Pain: "Classification of chronic pain: Descriptions of chronic pain syndromes and definitions of pain terms." Seattle: IASP Press, 1995.
3. Loeser JD: "Perspectives on Pain. Clinical Pharmacology and Therapeutics." Baltimore: University Park Press, 1980.
4. Tunks E, Crook J, Norman G, Kalaher S: Tender points in fibromyalgia. Pain 34:11-19, 1988.
5. Carette S, McCain GA, Bell DA, Fam AG: Evaluation of amitriptyline in primary fibrositis. A double-blind, placebo-controlled study. Arthritis Rheum 29:655-659, 1986.
6. Scudds RA, McCain GA, Rollman GB, Harth M: Improvements in pain responsiveness in patients with fibrositis after successful treatment with amitriptyline. J Rheumatol 16 (Suppl 19):113-119, 1989.
7. Leavitt F, Katz RS, Golden HE, Glickman PB, Layfer LF: Comparison of pain properties in fibromyalgia patients and rheumatoid arthritis patients. Arthritis Rheum 29:775-781, 1986.
8. Yunus MB, Masi AT, Aldag JC: A controlled study of primary fibromyalgia syndrome: Clinical features and association with other functional syndromes. J Rheumatol 16 (Suppl 19): 62-71, 1989.
9. Scudds RA, Rollman GB, Harth M, McCain GA: Pain perception and personality measures as discriminators in the classification of fibrositis. J Rheumatol 14:563-569, 1987.
10. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, Fam AG, Farber SJ, Fiechtner JJ, Franklin CM, Gatter RA, Hamaty D, Lessard J, Licthbroun AS, Masi AT, McCain GA, Reynolds WJ, Romano TJ, Russell IJ, Sheon RP: The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33:160-172, 1990.
11. McCain GA, Scudds RA: The concept of primary fibromyalgia (fibrositis): clinical value, relation and significance to other musculoskeletal pain syndromes. Pain 33:273-287, 1988.
12. Tunks E, McCain GA, Hart LE, Teasell RW, Rollman GB, DeShane PJ, McDermid AJ, Goldsmith C: The reliability of physical findings in patients with fibromyalgia and myofascial pain syndromes. Arthritis Rheum 34:S190, 1991 (Abstract).
13. Tunks E, McCain GA, Hart LE, Teasell RW, Goldsmith CH, Rollman GB, McDermid AJ, DeShane PJ: The reliability of examination for tenderness in patients with myofascial pain, chronic fibromyalgia and controls. J Rheumatol 22: 944-952, 1995.
14. Wolfe F, Simons DG, Fricton JR, Bennett RM, Goldenberg DL, Gerwin R, Hathaway D, McCain GA, Russell IJ, Sanders HO, Skootsky SA: The fibromyalgia and myofascial pain syndromes: A preliminary study of tender points and trigger points in persons with fibromyalgia, myofascial pain syndrome and no disease. J Rheumatol 19(6):944-951, 1992.
15. Wolfe F, Cathey MA: Prevalence of primary and secondary fibrositis. J Rheumatol 10:965-968, 1983.
16. Hartz A, Kirchdoerfer E: Undetected frbrositis in primary care practice. J Fam Pract 25:365-369, 1987.
17. Dinerman H, Goldenberg DL, Felson DT: A prospective evaluation of 118 patients with the fibromyalgia syndrome: prevalence of Raynaud's phenomenon, sicca symptoms, ANA, low complement, and Ig deposition at the dermal-epidermal junction. J Rheumatol 13:368-373, 1986.
18. Croft P, Rigby AS, Boswell R, Schollum J, Silman A: The prevalence of chronic widespread pain in the general poulation. J Rheumatol 20:710-713, 1993.
19. Lydell C, Myers, OL: The prevalence of fibromyalgia in a South African community. Scandinavian J Rheumatol (Suppl 94): 8, 1992 (Abstract).
20. Buskila D, Press J, Gedalia A, Klein M, Neumann R, Boehm R, Sukenij S: Assessment of non-articular tenderness and prevalence of fibromyalgia in children. J Rheumatol 20:368-370, 1993.
21. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L: The prevalence and characteristics of fibromyalgia in the general population. Arthritis & Rheumatism 38(1):19-28, 1995.
22. Wolfe F, Ross K, Anderson J, Russell IJ: Aspects of fibromyalgia in the general population: Sex, pain threshold and fibromyalgia symptoms. J Rheumatol 22:151-156, 1995.
23. Schochat T, Croft P, Raspe H: The epidemiology of fibromyalgia. Workshop of the Standing Committee on Epidemiology, European League Against Rheumatism (EULAR), Bad Sackingen, 19-21 November 1992. Br J Rheumatol 33(8):783-786, 1994.
24. Prescott E, Kjøler M, Jacobsen S, Bülow P, Danneskiold-Samsøe B, Kamper-Jørgensen F: Fibromyalgia in adult Danish population: A prevalence study. Scand J Rheumatol 122:233-237, 1993.
25. White KP, Speechley M, Harth M, Ostbye T: Fibromyalgia in rheumatology practice: A survey of Canadian rheumatologists. J Rheumatol 22:722-726, 1995.
26. Bradley EM, Webster GK, Rasooly I: The impact of musculoskeletal disorders in the population: Are they just aches and pains? Findings from the 1990 Ontario Health Survey. J Rheumatol 22:733-739, 1995.
27. Granges G, Silko P, Littlejohn GO: Fibromyalgia syndrome-assessment of the severity of the condition 2 years after diagnosis. J Rheumatol 21:523-529, 1994.
28. Dinerman H, Steere AC: Lyme disease associated with fibromyalgia. Ann Intern Med 117:281-285, 1992.
29. Sigal LH: Management of Lyme disease refractory to antibiotic therapy. Rheum Dis Clin N Am 21(1):217-230, 1995.
30. Sigal LH, Patella SJ: Lyme arthritis as the incorrect diagnosis in pediatric and adolescent fibromyalgia. Pediatrics 90:523-528, 1992.
31. Steere AC, Taylor E, McHugh GL, Logigian EL: The overdiagnosis of Lyme disease. JAMA 269:1812-1816, 1993.
32. Buchwald D, Goldenberg DL, Sullivan JL, Komaroff AL: The 'chronic, active Epstein-Barr virus infection' syndrome and primary fibromyalgia. Arthritis Rheum 30:1132-1136, 1987.
33. Goldenberg DL, Simms RW, Geiger A, Komaroff AL: High frequency of fibromyalgia in patients with chronic fatigue seen in a primary care practice. Arthritis & Rheumatism 33:381-387, 1990.
34. Wysenbeek AJ, Shapira Y, Leibovici L: Primary fibromyalgia and the chronic fatigue syndrome. Rheumatol Int 10:227-229, 1991.
35. Carette S, McCain GA, Bell DA, Fam AG: Evaluation of amitriptyline in primary fibrositis. Arthritis Rheum 29:655-659, 1986.
36. Goldenberg DL, Felson DT, Dinerman H: A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia. Arthritis Rheum 29:1371-1377, 1986.
37. Jaeschke R, Adachi J, Guyatt G, Keller J, Wong B: Clinical usefulness of amitriptyline in fibromyalgia: The results of 23 N-of-1 randomized, controlled trials. J Rheumatol 18:447-451, 1991.
38. Reynolds WJ, Moldofsky H, Saskin P, Lue FA: The effects of cyclobenza-prine on sleep physiology and symptoms in patients with fibromyalgia. J Rheumatol 18:452-454, 1991.
39. Bennett RM, Gatter RA, Campbell SM, Andrews RP, Clark SR, Scarlo JA: A comparison of cyclobenzaprine and placebo in the management of fibrositis. Arthritis Rheum 31(12):1535-1542, 1988.
40. Quimby LG, Gratwick GM, Whitney CA, Block SR: A randomized trial of cyclobenzaprine for the treatment of fibromyalgia. J Rheumatol 16 (Suppl 19): 140-143, 1989.
41. Santandrea S, Montrone F, Sarzi-Puttini P, Boccassini L, Caruso I: A double-blind crossover study of two cyclobenzaprine regimens in primary fibromyalgia syndrome. Journal of International Research 21:74-80, 1993.
42. Hamaty D, Valentine JL, Howard R, Howard CW, Wakefield V, Patten MS: The plasma endorphin, prostaglandin and catecholamine profile of patients with fibrositis treated with cyclobenzaprine and placebo: A five month study. J Rheumatol 16:S164-S168, 1989.
43. Stratz T, Menne T, Benn HPE: Blocking of S2 receptors: A new treatment principle in generalized tendo myopathy (fibromyalgia). Ziets Fur Rheumatol 50:21-22, 1991.
44. Finestone DH: Fluoxetine and fibromyalgia. JAMA 264(22):2869-2870, 1990.
45. Geller SA: Treatment of fibrositis with fluoxetine hydrochloride (prozac). Am J Med 87:594-595, 1989.
46. Cortet B, Houvenagel E, Forzy GE: Evaluation of the effectiveness of serotonin (fluoxetine hydrochloride) treatment: Open study in fibromyalgia. Revue Du Rheum Mal Osteo-Articulaires 59:497-500, 1992.
47. Russell IJ, Fletcher EM, Michalek JE, McBroom PC, Hester GG: Treatment of primary fibrositis/fibromyalgia syndrome with ibuprofen and alprazolam: A double-blind, placebo-controlled study. Arthritis Rheum 34:552-560, 1991.
48. Wysenbeek AJ, Nor F, Lurie T, Weinburger A: Imipramine for the treatment of fibrositis: a therapeutic trial. Ann Rheum Dis 44(11):752-753, 1985.
49. Bibolotti E, Borghi C, Paculli E: The management of fibrositis: A double-blind comparison of maprotiline, chlorimipramine, and placebo. Clin Trials J 23:269-280, 1986.
50. Wilke WS: Treatment of "resistant" fibromyalgia. Rheum Dis Clin N Am 21(1):247-260, 1995.
51. Moldofsky H, Warsh JJ: Plasma tryptophan and musculoskeletal pain in non-articular rheumatism. Pain 5:65-71, 1978.
52. Caruso I, Sarzi-Puttini PC, Boccassini L, Sanandrea S, Locati M, Volpato R, Montrone F, Benvenuti C, Beretta A: Double-blind study of dothiepin versus placebo in the treatment of primary fibromyalgia syndrome. J Int Med Res 15:154-159, 1987.
53. Bengtsson A, Bengtsson M: Regional sympathetic blockade in primary fibromyalgia. Pain 33:161-167, 1988 (Abstract).
54. Clark SR, Tindall EA, Bennett RA: A double-blind crossover trial of prednisone versus placebo in the treatment of fibrositis. J Rheumatol 12:980-983, 1985.
55. Tavoni A, Vitali C, Bombardieri S: Evaluation of S-adenosyl-methionine in primary fibromyalgia. Am J Med 83 (Suppl 5A):107-110, 1987.
56. Drewes AM, Andreasen A, Jennum P, Nielsen KD: Zopiclone in the treatment of sleep abnormalities in fibromyalgia. Scand J Rheumatol 20:288-293, 1991.
57. Silverman SL, Wallace DJ: Calcitonin helps a subset of patients with fibromyalgia. Arthritis & Rheumatism 34 (5) (Suppl):R21, 1991.
58. Vaeory H, Abrahamsen A, Forre O: Treatment of fibromyalgia (fibrositis syndrome): A parallel double-blind trial with carisoprodol, paracetamol, and caffeine versus placebo. Clin Rheumatology 8:245-250, 1989.
59. Russell IJ, Michalek JE, Flechas JD, Abraham GE: Treatment of fibromyalgia with Super Malic: A random, double-blind, placebo-controlled, crossover pilot study. J Rheumatol 22:953-958, 1995.
60. Bennett RM, Clark SR, Goldberg L, Nelson D, Bonafide RP, Porter J, Specht D: Aerobic fitness in the fibrositis syndrome: a controlled study of respiratory gas exchange and 133 xenon clearance from exercise in muscle. Arthritis Rheum 32(4):454-460, 1989.
61. McCain GA: Non-medicinal treatments in fibromyalgia. Rheum Dis Clin N Am 15(1):73-90, 1989.
62. McCain GA, Bell DA, Mai F, Halliday PD: A controlled study of the effects of a supervised cardiovascular fitness training program on the manifestations of the primary fibromyalgia syndrome. Arthritis Rheum 31(9):1135-1141, 1988.
63. McCain GA, Bell DA, Mai FM, Halliday PD: A controlled study of the effects of a supervised cardiovascular fitness program on the manifestations of the primary fibromyalgia syndrome. A&R Primary Care Review 2(4):1-15, 1990.
64. McCain GA: Role of physical fitness training in the fibrositis/fibromyalgia syndrome. Am J Med 81 (Suppl 3A):73-77, 1986.
65. Burckhardt CS, Mannerkorpi K, Hedenberg L, Bjelle A: A randomized controlled clinical trial of education and physical training for women with fibromyalgia. J Rheumatol 21:714-720, 1994.
66. Martin L, Edworthy SM, MacIntosh B, Nutting A, Butterwick D, Cook J: Is exercise helpful in treatment of fibromyalgia? Arthritis & Rheumatism 36(9) (Suppl):S251, 1993.
67. Mengshoel AM, Aomnaes HB, Forre O: The effects of 20 weeks of physical fitness in females with fibromyalgia. Clin Exp Rheumatol 10:345-349, 1992.
68. Furaccioli G, Chirelli L, Scita F, Nolli M, Mozzani M, Fontana S, Scorsonelli M, Trident A, DeRiso C: EMG-biofeedback training in fibromyalgia syndrome. J Rheumatol 14:820-825, 1987.
69. Deluze C, Bosia L, Zirbs A, Chantraine A, Vischer TL: Electroacupuncture in fibromyalgia: results of a controlled trial. Br Med J 305:1249-1252, 1992.
70. Waylonis G: Subcutaneous electrical stimulation (acupuncture) in the clinical practice of physical medicine. Arch Phys Med Rehabil 57:161-165, 1976.
71. Waylonis G: Long term follow-up on patients with fibrositis treated with acupuncture. Ohio State Medical Journal 73:299-302, 1977.
72. Lautenschager J, Schnorrenberger CC, Muller W: Akupunktur bei generalisierter tendomyopathie (fibromyalgie-syndrom). Dtsch Zschr Akup 6:122-128, 1989.
73. Hannen HCM, Hoenderdos HTW, Van Romunde LKJ, Hop WCJ, Mallee C, Terwiel JP, Hekster B: Controlled trial of hypnotherapy in the treatment of refractory fibromyalgia. J Rheumatol 18:72-75, 1991.
74. Nielson WR, Walker C, McCain GA: Cognitive Behavioral Treatment of Fibromyalgia Syndrome: Preliminary Findings. J Rheumatol 19:98-103, 1992.
75. White KP, Nielson WR: Cognitive behavioral treatment of fibromyalgia syndrome: A follow-up assessment. J Rheumatol 22:717-721, 1995.
76. Kaplan KH, Goldenberg DL, Galvin-Nadeau M: The impact of a meditation-based stress reduction program on fibromyalgia. General Hospital Psychiatry 15:284-289, 1993.
77. Nichols DS, Glenn TM: Effects of aerobic exercise on pain perception, affect, and level of disability in individuals with fibromyalgia. Physical Therapy 74(4):327-332, 1994.
78. Molina E, Cecchettin M, Fontana S: Failure of EMG-BF after sham BF training in fibromyalgia. Fed Proc 46:1357, 1987.
79. Bradley LA: Cognitive behavioral therapy for fibromyalgia. J Rheumatol 16(Suppl):131-136, 1989.